$VAR News
Last published 11mo ago
- 11mo agoVARVarian Medical Systems International AG. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 1y agoVARVarian Medical Systems - Appeal, ReversedUS Patent Trial and Appeal Board
- 1y agoVARVarian Medical Systems International AG - Appeal, AffirmedUS Patent Trial and Appeal Board
- 1y agoVARVarian Medical Systems, Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 2y agoVARVarian Medical Systems, Inc. - Appeal, AffirmedUS Patent Trial and Appeal Board
- 2y agoVARVarian Medical Systems International AG - Appeal, AffirmedUS Patent Trial and Appeal Board
- 3y agoVARAdaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma - NCT06108206ClinicalTrials.govPrediction of progression of disease in patients with high-grade glioma., Estimate the progression-free and overall survival in patient with high-grade glioma.
- 3y agoVARCryoanalgesia to Treat Phantom Limb Pain Following Above-Knee Amputation - NCT06071715ClinicalTrials.govAverage pain intensity change from baseline 1 month post-intervention, Average Daily Phantom Pain intensity change from baseline, Worst Daily Phantom Pain intensity change from baseline, (and 30 more...)
- 3y agoVARA Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue - NCT05837767ClinicalTrials.govOverall Response Rate (ORR)
- 3y agoVARAdaptive Radiation in Anal Cancer - NCT05838391ClinicalTrials.govTime to plan and deliver treatment fractions., Acute Treatment Toxicity, Complete Clinical Response Rate
- 3y agoVARDaily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer - NCT05804318ClinicalTrials.govPatient-reported acute urinary toxicity, Freedom from biochemical recurrence, Patient-reported quality of life issues related to prostate cancer., (and 11 more...)
- 3y agoVARStereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study - NCT05802186ClinicalTrials.govLocal failure free survival (LFS), LFS, Progression-free survival (PFS), (and 3 more...)
- 3y agoVARComputed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Central and Ultra-Central Early-Stage Non-Small Cell Lung Cancer - NCT05785845ClinicalTrials.govRate of grade 3 or greater toxicity
- 3y agoVARBest Medical International, Inc. vs Varian Medical Systems, Inc. et al. - AIA Trial, AffirmedUS Patent Trial and Appeal Board
- 3y agoVARvGRID SBRT: A Phase I Clinical Trial in Unresectable HCC - NCT05727787ClinicalTrials.govMaximum tolerated dose (MTD) of Single Fraction GRID SBRT, Local control utilizing RECIST v1.1 for HCC., Regional failure utilizing RECIST v1.1 for HCC., (and 3 more...)
- 3y agoVARDaily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer - NCT05700227ClinicalTrials.govAcute GI/GU Toxicity, Loco-regional Tumor Control, Patient-reported Quality of Life, (and 11 more...)
- 3y agoVARPerfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee - NCT05700682ClinicalTrials.govPrimary Clinical Outcome (Hip and Knee, Therapeutic Arm Only), Primary Clinical Outcome (Shoulder, Therapeutic Arm Only), Primary Imaging Outcome (Therapeutic Arm Only), (and 3 more...)
- 3y agoVAROn-treatment Adaptation of Head and Neck Cancer Dosimetry Plans Using Novel Cone-beam CT and AI-driven Software - NCT05666193ClinicalTrials.govEvaluation of CBCT-based dosimetry calculations, Evaluate potential reduction in time and resources required for offline plan adaptation, Improvements in radiation dosimetry from using online adaptation, (and 3 more...)
- 3y agoVARAdaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer - NCT05628363ClinicalTrials.govRate of acute grade ≥3 GI and GU adverse events, Changes in patient-reported quality of life as measured by EPIC-26, Changes in global function as measured by EQ-5D-5L, (and 16 more...)
- 4y agoVARLu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy - NCT05560659ClinicalTrials.govEvaluate the (bPFS) of SABR alone and SABR + 177Lu-PSMA, The AEs according to CTCAE v5.0, The PSA-response rate, (and 6 more...)
- 4y agoVAREvaluation of a Cone-beam CT Scanner for Image Guided Radiotherapy - NCT05524454ClinicalTrials.govImage quality, Image suitability for radiation dose calculation, Qualitative assessment of novel CBCT images
- 4y agoVARSplit Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer - NCT05501665ClinicalTrials.govIncidence of adverse events, Best overall response rate, Progression free survival (PFS), (and 3 more...)
- 4y agoVARDaily Adaptive Radiation Therapy: An Individualized Approach for Stage III Lung Cancer - NCT05488626ClinicalTrials.govAcute toxicity, Lung cancer specific quality of life, Global quality of life, (and 5 more...)
- 4y agoVARVarian ProBeam Proton Therapy System China Clinical Trial (Hefei) - NCT05463055ClinicalTrials.govtumor disease control rate reaches the objective performance criteria (80%), CTCAE level 3 toxic reaction ratio is lower than the acceptable value (5%), CTCAE level 4 and 5 toxic reaction ratio is acceptable value (0%), (and 8 more...)
- 4y agoVARImaging Study on Halcyon 4.0 System for Patients Receiving Radiation Therapy - NCT05427214ClinicalTrials.govPercentage of images that are of sufficient quality for patient primary treatment plan construction
- 4y agoVAR"Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)" - NCT05410509ClinicalTrials.govThe number of patients experiencing major adverse events defined as anything grade C or above by Society of Interventional Radiology Guidelines.
- 4y agoVARAVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc - NCT05351424ClinicalTrials.govRadiation Therapy (RT) Knowledge Questionnaire, Radiation Therapy (RT) Adherence Score, Radiation Therapy (RT) Satisfaction Questionnaire, (and 2 more...)
- 4y agoVARRe-optimization Based Online Adaptive Radiotherapy of Bladder Cancer - NCT05295992ClinicalTrials.govEarly Rate CTCAE GI Toxicity, All Early CTCAE Treatment Related Toxicities, All Late CTCAE Treatment Related Toxicities, (and 10 more...)
- 4y agoVARHyperArc Registry Study - NCT05270707ClinicalTrials.govSurvival, Local tumor control, HyperArc Patterns of Care
- 4y agoVAREvaluation of Novel Cone-Beam CT for Guidance and Adaptation of Precision Radiotherapy - NCT05176860ClinicalTrials.govCBCT Image Quality, Dosimetry Calculations, Patient Experience
- 4y agoVARA Prospective Study to Evaluate Continuous Positive Airway Pressure Devices to Reduce Pulmonary Dose - NCT05142358ClinicalTrials.govDosimetry comparison CPAP and free breathing., Total Lung dosimetry, Cardiac dosimetry with CPAP as compared to free breathing, (and 3 more...)
- 4y agoVARVarian Medical Systems, Inc. - Appeal, ReversedUS Patent Trial and Appeal Board
- 5y agoVARDigital Symptom Tracking, Patient Engagement and Quality of Life in Advanced Cancer - NCT05112198ClinicalTrials.govProportion of patients with at least one symptom questionnaire (SQ) completed after enrollment using the PROMIS platform, Change in PROMIS-G physical subscale score, Change in PROMIS-G mental subscale score, (and 6 more...)
- 5y agoVARSimulation-Free Hippocampal-Avoidance Whole Brain Radiotherapy Using Diagnostic MRI-Based and Cone Beam Computed Tomography-Guided On-Table Adaptive Planning in a Novel Ring Gantry Radiotherapy Device - NCT05096286ClinicalTrials.govFeasibility of the simulation-free hippocampal-avoidance whole brain radiotherapy (HA-WBRT) as measured by the successful completion of the simulation-free HA-WBRT workflow through treatment delivery
- 5y agoVARLocal Consolidative Therapy in Colorectal Cancer - NCT05062720ClinicalTrials.govProgression free survival, Overall suvival (OS), Patient reported outcomes (PROs)
- 5y agoVARRAPid SimPLE Targeted Radiation Treatment for Brain Metastases - NCT05050929ClinicalTrials.govSurvival Time, Median Time to Decline in Karnofsky Performance Status, Control of treated brain metastases, (and 5 more...)
- 5y agoVARNovel Optical Surface Image Guidance System for Beam-Gated Online Adaptive SBRT Delivery in Mobile Lower Lung and Upper Abdominal Malignancies - NCT05030454ClinicalTrials.govPercentage of scheduled treatment fractions delivered successfully using the surface guidance system
- 5y agoVARIcon Group First in World to Adopt New Multi-Disciplinary Oncology Information System from VarianPR NewswirePALO ALTO, Calif., Aug. 5, 2021 /PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that cancer patients in Australia will be the first in the world to benefit from streamlined, coordinated cancer care facilitated by an upcoming relea
- 5y agoVARFeasibility of Telehealth Palliative Care and Digital Symptom Monitoring for Patients With Acute Myeloid Leukemia - NCT04885127ClinicalTrials.govRate of completed palliative care referrals and monthly visits, Rate of usage of digital symptom monitoring application, Noona, Mean change in Functional Assessment of Cancer Therapy-Leukemia (FACT-Leu) scores, (and 4 more...)
- 5y agoVARVarian and Icon Group Partner to Extend Commitment to Global Cancer CarePR NewswirePALO ALTO, Calif., April 27, 2021 /PRNewswire/ -- Varian (NYSE:VAR), a Siemens Healthineers company, has signed an agreement with Australia's Icon Group to provide 30 linear accelerators and associated treatment software to help tackle the growing globa
- 5y agoVARBest Medical International, Inc. vs Varian Medical Systems, Inc. - AIA Trial, TerminationUS Patent Trial and Appeal Board
- 5y agoVARBest Medical International, Inc. vs Varian Medical Systems, Inc. - AIA Trial, TerminationUS Patent Trial and Appeal Board
- 5y agoVARUFSTYLSPGIPTC Set to Join S&P 500; Lattice Semiconductor & Progyny to Join S&P MidCap 400; Domtar to Join S&P SmallCap 600PR NewswireS&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the open of trading on...
- 5y agoVARVarian Medical Systems International AG - Appeal, AffirmedUS Patent Trial and Appeal Board
- 5y agoVARVarian Wins Best After-Sales Service Award for Radiotherapy Products in China for Fourth Consecutive YearPR NewswireVarian (NYSE: VAR) today announced it received the Best After-Sales Service Award for Radiotherapy Products in the 2020 Chinese Medical Devices...
- 5y agoVARVarian and Google Cloud Collaborate to Aid in the Fight Against CancerPR NewswireVarian (NYSE: VAR) today announced it is collaborating with Google Cloud to build an advanced artificial intelligence (AI) based diagnostic platform...
- 5y agoVARNew patent application published for: Dose-Distribution Estimation in Proton TherapyUS Patent Applications (USPTO)( 1 of 1 )
- 5y agoVARVarian Medical Systems Invests in Bend It Technologies, Ltd., a Company Developing Novel Steerable MicrocathetersPR NewswireVarian (NYSE: VAR) today announced a new investment in Bend It Technologies Ltd., a medical device company based in Petach Tikva, Israel, that is...
- 5y agoVARVarian Announces CEO Succession PlanPR NewswireVarian (NYSE: VAR) today announced that Chief Executive Officer Dow Wilson, after more than 16 years with the Company, will retire upon the...
- 5y agoVARCTSI Oncology Solutions, a Varian Company, to Provide Technology-Enabled Services for Radiation Oncology at CHRISTUS HealthPR NewswireCTSI Oncology Solutions, a Varian (NYSE: VAR) company that provides oncology services for healthcare providers worldwide, has entered into a...